Q2 2026 13F · SEC CIK 1712901
Melqart Asset Management (UK) Ltd
Hedge fundFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $1.1B
- Reported positions
- 40
- Top holdings a year, 3 yrs
- +18.0%
- Assets under management
- $2.9B
Melqart Asset Management (UK) Ltd is a hedge fund that reported 40 positions worth $1.1B in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Warner Bros Discovery Inc (WBD, 11.6%), Txnm Energy Inc (TXNM, 7.4%), Norfolk Southn Corporation (NSC, 7.3%). A portfolio copying its top holdings returned 18.0% a year over the last 3 years, against 17.9% for the S&P 500.
Melqart Asset Management (UK) Ltd holdings all 40 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Melqart Asset Management (UK) Ltd bought and sold in Q2 2026, against Q1 2026.
New positions
- ABVX Abivax SA3.9% of 13F
- Caesars Entertainment Inc Ne1.9% of 13F
- AMZN Amazon Com Inc1.5% of 13F
- APGE Apogee Therapeutics Inc1.5% of 13F
- LRCX Lam Research Corp1.3% of 13F
- ANET Arista Networks Inc1.3% of 13F
- ARES Ares Management Corp1.1% of 13F
- STX Seagate Technology Hldngs Pl1.1% of 13F
Added to
- TWO Two Harbors Investment Corp.+218.7% shares
- AES AES Corp+128.8% shares
- PEN Penumbra, Inc.+127.0% shares
- WBD Warner Bros Discovery Inc+126.1% shares
- EURN Cmb.tech NV+98.6% shares
- NSC Norfolk Southn Corporation+51.0% shares
- TXNM Txnm Energy Inc+30.4% shares
- GPN Global Pmts Inc+24.1% shares
Reduced
- SNDK Sandisk Corp-88.1% shares
- MRVL Marvell Technology Inc-80.7% shares
- TSM Taiwan Semiconductor Manufac-63.2% shares
- AXTA Axalta Coating Sys Ltd-62.5% shares
- RVMD Revolution Medicines Inc-55.1% shares
- NVDA Nvidia Corporation-49.4% shares
- AMD Advanced Micro Devices Inc-32.8% shares
- ASML Asml Hldg NV-32.0% shares
Sold out
- CWAN Clearwater Analytics Hldgs Iwas 5.3%
- KVUE Kenvue Incwas 4.3%
- TERN Terns Pharmaceuticals Incwas 2.6%
- FN Fabrinetwas 2.3%
- AVGO Broadcom Incwas 2.2%
- VSNTV Versant Media Group Incwas 2.0%
- WDC Western Digital Corp Comwas 1.7%
- FWRD Forward Air Corpwas 1.4%
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- +62.7% /yr
- S&P 500 +22.0%
- 3 years
- +18.0% /yr
- S&P 500 +17.9%
- 5 years
- +11.0% /yr
- S&P 500 +9.4%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $1.1B | 40 |
| Q1 2026 | $1.0B | 41 |
| Q4 2025 | $999.5M | 44 |
| Q3 2025 | $749.5M | 44 |
| Q2 2025 | $699.7M | 30 |
| Q1 2025 | $740.3M | 45 |
| Q4 2024 | $743.0M | 42 |
| Q3 2024 | $1.0B | 46 |
| Q2 2024 | $1.1B | 49 |
| Q1 2024 | $1.3B | 45 |
| Q4 2023 | $1.2B | 36 |
| Q3 2023 | $1.4B | 35 |
Questions about Melqart Asset Management (UK) Ltd's portfolio
What stocks does Melqart Asset Management (UK) Ltd own?
Melqart Asset Management (UK) Ltd's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 40 positions worth $1.1B. The largest are Warner Bros Discovery Inc (WBD) at 11.6%, Txnm Energy Inc (TXNM) at 7.4%, Norfolk Southn Corporation (NSC) at 7.3%, Electronic Arts Inc (EA) at 7.0% and Cytokinetics (CYTK) at 6.2%.
What did Melqart Asset Management (UK) Ltd buy last quarter?
In Q2 2026, Melqart Asset Management (UK) Ltd added a new position in Abivax SA (ABVX), a new position in Caesars Entertainment Inc Ne, a new position in Amazon Com Inc (AMZN), a new position in Apogee Therapeutics Inc (APGE), a new position in Lam Research Corp (LRCX), Two Harbors Investment Corp. (TWO) (+218.7% shares), AES Corp (AES) (+128.8% shares) and Penumbra, Inc. (PEN) (+127.0% shares), compared with its Q1 2026 filing.
What did Melqart Asset Management (UK) Ltd sell last quarter?
In Q2 2026, Melqart Asset Management (UK) Ltd sold all of Clearwater Analytics Hldgs I (CWAN), sold all of Kenvue Inc (KVUE), sold all of Terns Pharmaceuticals Inc (TERN), sold all of Fabrinet (FN), sold all of Broadcom Inc (AVGO), Sandisk Corp (SNDK) (-88.1% shares), Marvell Technology Inc (MRVL) (-80.7% shares) and Taiwan Semiconductor Manufac (TSM) (-63.2% shares), compared with its Q1 2026 filing.
How has Melqart Asset Management (UK) Ltd's portfolio performed?
A portfolio copying Melqart Asset Management (UK) Ltd's 20 largest 13F holdings each quarter, from the day each filing was public, returned +18.0% a year over the last 3 years, against +17.9% for the S&P 500. Over 1 year: +62.7% against +22.0%. Over 5 years: +11.0% a year against +9.4%.
When is Melqart Asset Management (UK) Ltd's next 13F filing due?
13F filings are due 45 days after each quarter ends. Melqart Asset Management (UK) Ltd's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Melqart Asset Management (UK) Ltd manage?
Melqart Asset Management (UK) Ltd reported $2.9B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $1.1B.